Rapamycin Holdings Inc.
2 clinical trials · Sponsor
◉ Watch Rapamycin Holdings Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis (NCT06950385) | Rapamycin Holdings Inc. | 2025-07-18 |
| Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance (NCT04230499) | Rapamycin Holdings Inc. | 2021-01-18 |
Track Rapamycin Holdings Inc. automatically
Every clearance here is in the API, with alerts when new ones post.